Sav Szemethy

Sav Szemethy is a Principal Research Associate at TScan Therapeutics with extensive experience in developing novel TCR therapies and optimizing bioprocesses for cell therapy. Prior roles include Associate Scientist and Senior Research Associate at PlateletBio, where Sav contributed to the development of downstream bioprocesses and led technology transfers to manufacturing. Additional experience encompasses hands-on research at Perry Research Lab and Nyacol Nano Technologies, focusing on microfluidic device design and nanoparticle formulation, respectively. Sav holds a Bachelor of Applied Science in Chemical Engineering from the University of Massachusetts Amherst and has demonstrated strong analytical and presentation skills throughout various collaborative projects.